The Expression of Ras–GTPase Activating Protein SH3 Domain-binding Proteins, G3BPs, in Human Breast Cancers

被引:0
|
作者
Juliet French
Renée Stirling
Michael Walsh
Hendrick Daniel Kennedy
机构
[1] University of Queensland,Institute for Molecular Bioscience
[2] Griffith University,School of Biomolecular and Biomedical Science
[3] Royal Brisbane Hospital,Queensland Institute of Medical Research
来源
The Histochemical Journal | 2002年 / 34卷
关键词
Breast Cancer; Cancer Tissue; Human Breast Cancer; Human Chromosome; Breast Cancer Tissue;
D O I
暂无
中图分类号
学科分类号
摘要
Ras–GTPase activating protein SH3 domain-binding proteins 1 and 2 (G3BP1 and G3BP2) have recently been reported to be encoded by two separate genes on human chromosomes 5 and 4 respectively and have been implicated in Ras signalling, NFkappaB signalling, the ubiquitin proteosome pathway and RNA processing. In addition, G3BP1 has recently been implicated in cancer biology. The transcripts for these genes have been shown to be universally expressed; however, this is not the case for the proteins which appear to be tissue and cell type specific. We report here the expression of G3BP1 and 2 in human breast cancers and present the first data showing that G3BP2 expression is specific in human breast cancer tissue and was over-expressed in 88% of tumours examined (n = 58).
引用
收藏
页码:223 / 231
页数:8
相关论文
共 50 条
  • [1] The expression of Ras-GTPase activating protein SH3 domain-binding proteins, G3BPs, in human breast cancers
    French, J
    Stirling, R
    Walsh, M
    Kennedy, HD
    HISTOCHEMICAL JOURNAL, 2002, 34 (05): : 223 - 231
  • [2] An alliance between Ras GTPase-activating protein, filamin C, and Ras GTPase-activating protein SH3 domain-binding protein regulates myocyte growth
    Lypowy, J
    Chen, IY
    Abdellatif, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) : 25717 - 25728
  • [3] Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
    N Oi
    J Yuan
    M Malakhova
    K Luo
    Y Li
    J Ryu
    L Zhang
    A M Bode
    Z Xu
    Y Li
    Z Lou
    Z Dong
    Oncogene, 2015, 34 : 2660 - 2671
  • [4] Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
    Oi, N.
    Yuan, J.
    Malakhova, M.
    Luo, K.
    Li, Y.
    Ryu, J.
    Zhang, L.
    Bode, A. M.
    Xu, Z.
    Li, Y.
    Lou, Z.
    Dong, Z.
    ONCOGENE, 2015, 34 (20) : 2660 - 2671
  • [5] THE RAS GTPASE-ACTIVATING PROTEIN (GAP) IS AN SH3 DOMAIN-BINDING PROTEIN AND SUBSTRATE FOR THE SRC-RELATED TYROSINE KINASE, HCK
    BRIGGS, SD
    BRYANT, SS
    JOVE, R
    SANDERSON, SD
    SMITHGALL, TE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14718 - 14724
  • [6] Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients
    Min, Lingqiang
    Ruan, Yuanyuan
    Shen, Zhenbin
    Jia, Dongwei
    Wang, Xuefei
    Zhao, Junjie
    Sun, Yihong
    Gu, Jianxin
    HISTOPATHOLOGY, 2015, 67 (05) : 677 - 688
  • [7] Nck SH3 domain-binding proteins.
    Song, YH
    Park, JS
    Park, D
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2900 - 2900
  • [8] Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1
    Fan Yang
    Lin Li
    Zhenzhen Mu
    Pengyue Liu
    Ying Wang
    Yue Zhang
    Xiuping Han
    Cancer Gene Therapy, 2022, 29 : 1939 - 1950
  • [9] Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras-GTPase-Activating Protein SH3 Domain-Binding Protein 1
    Shim, Jung-Hyun
    Su, Zheng-Yuan
    Chae, Jung-Il
    Kim, Dong Joon
    Zhu, Feng
    Ma, Wei-Ya
    Bode, Ann M.
    Yang, Chung S.
    Dong, Zigang
    CANCER PREVENTION RESEARCH, 2010, 3 (05) : 670 - 679
  • [10] Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1
    Yang, Fan
    Li, Lin
    Mu, Zhenzhen
    Liu, Pengyue
    Wang, Ying
    Zhang, Yue
    Han, Xiuping
    CANCER GENE THERAPY, 2022, 29 (12) : 1939 - 1950